The objective of this proposal is to understand the signal transduction pathway responsible for hypoxia-induced erythropoietin (Epo) production. The Hep3B cell line has previously been shown to regulate Epo production in a physiologic manner in response to hypoxia. It has also been used extensively as a model system to study the effects of inflammatory cytokines in the acute phase response. The addition of IL-1 alpha, IL-1 beta, or TNF-alpha results in a dose-dependent inhibition of hypoxia- induced Epo production. In contrast, the addition of IL/6 to hypoxic Hep3B cells results in a dose-dependent further stimulation of hypoxia-induced Epo production. Northern blot analyses indicate that these cytokines affect Epo production primarily at the mRNA level. In this proposal the applicant plans to investigate the molecular mechanisms by which the inflammatory cytokines exert their effects on hypoxia-induced Epo production. Experiments will be performed to characterize the cis and trans elements which are involved in the transcriptional and post- transcriptional regulation of these cytokine mediated events. This work will involve extensive analysis of the 5' and 3' flanking regions of the Epo gene. Methods to be employed include functional assays (nuclear run- off transcription assays, transient expression assays, in vitro RNA degradation analyses) and structural analyses (DNA and RNA mobility shift assays, in vitro DNAse I footprint analysis, protein purification and characterization). The applicant will test the hypothesis that the soluble form of guanylate cyclase is the heme protein oxygen sensor which mediates the hypoxia-induced increase in Epo production. In an effort to unravel the hypoxia-induced signal transduction pathway, changes in phosphorylation of cytosolic and membrane proteins will be investigated. Oxygen differs from the great majority of external cell signals by being a ubiquitous molecule that diffuses readily into cells independent of receptor binding. Accordingly, the signal transduction pathway from oxygen sensor to gene regulation may differ significantly from these associated with classic ligand-receptor binding. Investigation of the molecular basis for the observed effects of these cytokines on hypoxia-induced Epo production may provide detailed information on the molecular nature of the oxygen sensor. In addition, a better understanding of the molecular mechanisms governing the regulation of Epo production may enhance our understanding of the pathogenesis of the anemia of chronic disease and the nature of the acute phase response.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK045098-01
Application #
3246658
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1992-05-15
Project End
1996-04-30
Budget Start
1992-05-15
Budget End
1993-04-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Jiang, Yide; Vasconcelles, Michael J; Wretzel, Sharon et al. (2002) Mga2p processing by hypoxia and unsaturated fatty acids in Saccharomyces cerevisiae: impact on LORE-dependent gene expression. Eukaryot Cell 1:481-90
Vasconcelles, M J; Jiang, Y; McDaid, K et al. (2001) Identification and characterization of a low oxygen response element involved in the hypoxic induction of a family of Saccharomyces cerevisiae genes. Implications for the conservation of oxygen sensing in eukaryotes. J Biol Chem 276:14374-84
Jiang, Y; Vasconcelles, M J; Wretzel, S et al. (2001) MGA2 is involved in the low-oxygen response element-dependent hypoxic induction of genes in Saccharomyces cerevisiae. Mol Cell Biol 21:6161-9
Huang, L E; Willmore, W G; Gu, J et al. (1999) Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J Biol Chem 274:9038-44
Levy, A P; Levy, N S; Iliopoulos, O et al. (1997) Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney Int 51:575-8
Levy, N S; Goldberg, M A; Levy, A P (1997) Sequencing of the human vascular endothelial growth factor (VEGF) 3' untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites. Biochim Biophys Acta 1352:167-73
Iliopoulos, O; Levy, A P; Jiang, C et al. (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A 93:10595-9
Levy, A P; Levy, N S; Goldberg, M A (1996) Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem 271:25492-7
Levy, A P; Levy, N S; Wegner, S et al. (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-40
Levy, A P; Levy, N S; Loscalzo, J et al. (1995) Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 76:758-66

Showing the most recent 10 out of 14 publications